IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9540345 B1

PDFFull Text
Date of Patent:
Jan. 10, 2017

Filed:

Mar. 03, 2014

Antiviral compounds

Applicant:

Hoffmann-la Roche Inc., Nutley, NJ (US);

Inventors:

Steven Joseph Berthel, Mendham Township, NJ (US);

Zhi Chen, Livingston, NJ (US);

Feng Chi, Basking Ridge, NJ (US);

Elbert Chin, San Mateo, CA (US);

David Shawn Erickson, Leonia, NJ (US);

Stephen Deems Gabriel, Morristown, NJ (US);

Buelent Kocer, Maulburg, DE;

Eric Mertz, Fair Lawn, NJ (US);

Jean-Marc Plancher, Hagenthal-le-Bas, FR;

Robert J. Weikert, Basel, DE;

Assignee:

HOFFMANN-LA ROCHE INC., Nutley, NJ (US);

Attorney:
Primary Examiner:

Alicia L Otton

Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 487/10 (2006.01); C07D 471/04 (2006.01); C07D 409/12 (2006.01); C07D 249/14 (2006.01); A61K 31/4196 (2006.01); A61K 31/437 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 31/4439 (2006.01); A61K 31/506 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/4196 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07D 249/14 (2013.01); C07D 403/12 (2013.01); C07D 409/12 (2013.01); C07D 471/04 (2013.01); C07D 487/10 (2013.01);
Abstract

The present invention discloses compounds of Formula (I): wherein the variables in Formula (I) are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula (I) in the prevention or treatment of HCV infection.

Find Patent Forward Citations

Loading…